However, the changes that occur in the SphK/S1P signaling pathways in normal compared to abnormal cells is still being unraveled and the involvement of SphK isozymes, isoforms, S1P and S1PR in the pathophysiology of cancer will be covered in more depth. This evidence concerns the gene SPHK1 and cancer.